COMP <GO>
CLNN vs HRTX // ENTERPRISE SCALE & MARKET CAP
Clene Inc. (NASDAQ) VS. Heron Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CLNN 3
— HRTX 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: HRTX
LAST: $3.90 (-3.23%) • MKT CAP: $55.4M
market-cap
$55.4M
LAST: $0.29 (-4.69%) • MKT CAP: $55.9M
market-cap
$55.9M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLNN VS. HRTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLNN | HRTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.50% | 73.30% | +5.20 | CLNN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -1.60% | -58.40 | HRTX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -12.90% | -47.10 | HRTX | /net-margins <GO> |
| Revenue Growth (YoY) | -41.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | CLNN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.4 | 37.6 | +11.83 | CLNN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $55.4M | $55.9M | -$458.0K | HRTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLNN REV | HRTX REV | CLNN GROSS % | HRTX GROSS % | CLNN FCF | HRTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $200.0K | $154.9M | 78.5% | 73.3% | -$18.6M | -$27.9M |
| FY 2024 | $342.0K | $144.3M | 79.5% | 73.2% | -$21.3M | -$24.2M |
| FY 2023 | $654.0K | $0 | — | — | -$30.2M | -$58.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLNN // BETA —
HRTX // BETA —